In addition, the drug delivery HSA-NP system can offer targeteddelivery of PD-L1 immunotherapeutics, which can make important contributionsto tumor immunotherapy and offer us a new perspective to address thelimitations mentioned above. The gene discussed is ALB; the disease is neoplasm.